AMA names a new president

Susan Bailey, MD, has been named the new president of American Medical Association, the group announced June 8 at the AMA’s annual meeting in Chicago. Bailey is an allergist and immunologist from Fort Worth, Texas, and she will serve as president-elect for a year before assuming the office in June 2020.

Her election marks the third consecutive time the leader of the industry group has served as a woman physician. Bailey was preceded by Barbara McAneny, MD, and Patrice Harris, MD.

“It is a deep honor and privilege to be named president-elect of an organization that is committed to helping the medical profession and the patients we serve,” Bailey said in her acceptance speech. “Challenging times remain for the health care system and as AMA president-elect, I pledge to serve as a strong voice and dedicated advocate for patients and physicians on the pressing healthcare issues confronting our nation.”

Bailey has more than 30 years of clinical practice and has been practicing allergy and clinical immunology in Texas since 1998. She has also served on the AMA board of trustees since 2011 as vice speaker and speaker of the house of delegates, which is the primary policy-making body of the organization.

In addition, Bailey has held several other leadership positions with AMA, including serving two terms on the AMA Council on Medical Education, serving as a member of the AMA’s Advisory Panel to the Women in Medicine Project and the AMA’s Ad Hoc Committee on Women Physicians.

Prior to becoming an officer at AMA, Bailey was president of the Texas Medical Association and Tarrant County Medical Society.

In addition to Bailey's appointment, the AMA named Bruce A. Scott, MD, an otolaryngologist from Louisville, Kentucky, as the new speaker of the AMA House of Delegates.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.